Case number IPR2024-00009
DR. REDDY'S LABORATORIES, INC. et al. v. Novo Nordisk A/S > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Jan 10, 2025 | 21 | board | Order: Order on Motions to Expunge Download |
| Jan 10, 2025 | 22 | board | Order: On Protective Orders and Motions to Seal Download |
| Jan 10, 2025 | 20 | board | Termination Decision: Post-DI Settlement Download |
| Apr 25, 2024 | 19 | board | Decision Granting Institution of Inter Partes Review Granting Motion for Joinder Download |
| Apr 3, 2024 | 18 | patent_owner | Patent Owner's Further Authorized Reply Download |
| Apr 3, 2024 | 2024 | patent_owner | EX2024 - Excerpt of Opening Expert Report of Dr. John Bantle Regarding Invalidity of U.S. Patent No. 10,335,462, In re: Ozempic (Semaglutide) Patent Litigation, No. 22-MD-03038-CFC (D. Del.) Download |
| Apr 3, 2024 | 2025 | patent_owner | EX2025 - Excerpt of Opening Expert Report of William J. Jusko, Ph.D. Regarding Invalidity of U.S. Patent No. 10,335,462, In re: Ozempic (Semaglutide) Patent Litigation, No. 22-MD-03038-CFC (D. Del.) Download |
| Apr 3, 2024 | 2026 | patent_owner | EX2026 - Excerpt of Opening Expert Report of Dr. Paul Dalby Regarding Invalidity of U.S. Patent No. 10,335,462, In re: Ozempic (Semaglutide) Patent Litigation, No. 22-MD-03038-CFC (D. Del.) Download |
| Mar 29, 2024 | 1098 | petitioner | District Court Order re Trial Date Download |
| Mar 29, 2024 | 1099 | petitioner | Proposed Stipulation Download |
| Mar 29, 2024 | 16 | board | Download |
| Mar 29, 2024 | 17 | petitioner | Updated Exhibit List Download |
| Mar 6, 2024 | 15 | patent_owner | Patent Owner's Sur-Reply Download |
| Feb 21, 2024 | 14 | petitioner | Download |
| Feb 13, 2024 | 3001 | board | Exhibit 3001 Download |
| Jan 26, 2024 | 13 | patent_owner | Preliminary Response Download |
| Jan 26, 2024 | 2001 | patent_owner | Download |
| Jan 26, 2024 | 2002 | patent_owner | EX2002 - Petition for Inter Partes Review, Mylan Pharms. Inc. v. Novo Nordisk A/S, IPR2023-00724, Pap.1 (Mar. 16, 2023) Download |
| Jan 26, 2024 | 2003 | patent_owner | EX2003 - Declaration of Sayem Osman Download |
| Jan 26, 2024 | 2004 | patent_owner | EX2004 - Stipulation and Order Regarding Trial of the MPI Ozempic Litigation, In re: Ozempic (Semaglutide) Patent Litigation, No. 22-MD-03038-CFC, Dkt. 245 (D. Del. Oct. 31, 2023) Download |
| Jan 26, 2024 | 2005 | patent_owner | Download |
| Jan 26, 2024 | 2006 | patent_owner | EX2006 - Scheduling Order, Novo Nordisk Inc. v. Rio Biopharms., Inc., No. 1:22-cv-00294-CFC, Dkt. 22 (D. Del.) Download |
| Jan 26, 2024 | 2007 | patent_owner | EX2007 - Excerpt of Transcript of Dec. 13, 2023 Claim Construction Hearing, Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc., No. 23-101-CFC (D. Del. Dec. 13, 2023) Download |
| Jan 26, 2024 | 2008 | patent_owner | EX2008 - Claim Construction Order, In re: Ozempic (Semaglutide) Patent Litigation, No. 22-MD-03038-CFC, Dkt. 148 (D. Del. July 25, 2023) Download |
| Jan 26, 2024 | 2009 | patent_owner | EX2009 - Joint Stipulation and Order Amending Scheduling Order, In re: Ozempic (Semaglutide) Patent Litigation, MDL No. 22-MD-03038-CFC, Dkt. 268 (D. Del. Dec. 1, 2023) Download |
| Jan 26, 2024 | 2010 | patent_owner | Download |
| Jan 26, 2024 | 2011 | patent_owner | EX2011 - U.S. Patent No. 8,114,833 Download |
| Jan 26, 2024 | 2012 | patent_owner | Download |
| Jan 26, 2024 | 2013 | patent_owner | Download |
| Jan 26, 2024 | 2014 | patent_owner | Download |
| Jan 26, 2024 | 2015 | patent_owner | Download |
| Jan 26, 2024 | 2016 | patent_owner | EX2016 - Transfer Order, In re: Ozempic (Semaglutide) Patent Litigation, No. 22-MD-03038-CFC, Dkt. 1 (D. Del. Aug. 5, 2022) Download |
| Jan 26, 2024 | 2018 | patent_owner | Download |
| Jan 26, 2024 | 2019 | patent_owner | EX2019 - Novo Nordisk Production Letter, In re: Ozempic (Semaglutide) Patent Litigation, No. 22-MD-03038-CFC (D. Del. Oct. 17, 2023) [REDACTED] Download |
| Jan 26, 2024 | 2020 | patent_owner | EX2020 - Novo Nordisk Production Letter, In re: Ozempic (Semaglutide) Patent Litigation, No. 22-MD-03038-CFC (D. Del. Oct. 17, 2023) [REDACTED] Download |
| Jan 26, 2024 | 2021 | patent_owner | EX2021 - Compilation of Rule 30(b)(1) Deposition Notices, In re: Ozempic (Semaglutide) Patent Litigation, No. 22-MD-03038-CFC (D. Del.) Download |
| Jan 26, 2024 | 2022 | patent_owner | Download |
| Jan 26, 2024 | 2023 | patent_owner | Download |
| Nov 20, 2023 | 12 | patent_own | Joint Stipulation Regarding Petitioners' Motion for Joinder Download |
| Nov 8, 2023 | 11 | board | Order: Conduct of the Proceeding 37 C.F.R. sec. 42.5 Download |
| Nov 1, 2023 | 10 | patent_own | Patent Owner's Mandatory Notices Download |
| Nov 1, 2023 | 5 | patent_own | Power of Attorney and Designation of Lead and Back-Up Counsel Download |
| Nov 1, 2023 | 6 | patent_own | Patent Owner's Mandatory Notices Download |
| Nov 1, 2023 | 7 | patent_own | Power of Attorney and Designation of Lead and Back-Up Counsel Download |
| Nov 1, 2023 | 8 | patent_own | Patent Owner's Mandatory Notices Download |
| Nov 1, 2023 | 9 | patent_own | Power of Attorney and Designation of Lead and Back-Up Counsel Download |
| Oct 26, 2023 | 4 | board | Notice: Notice filing date accorded Download |
| Oct 20, 2023 | 1 | petitioner | Petitioners DLR Power of Attorney Download |
| Oct 20, 2023 | 1001 | petitioner | U.S. Patent No. 10,335,462 Download |
| Oct 20, 2023 | 1002 | petitioner | Prosecution history excerpts for U.S. Patent No. 10,335,462 Download |
| Oct 20, 2023 | 1003 | petitioner | Declaration of John Bantle, MD Download |
| Oct 20, 2023 | 1004 | petitioner | CV of John Bantle, MD Download |
| Oct 20, 2023 | 1005 | petitioner | Declaration of William J. Jusko, Ph.D. Download |
| Oct 20, 2023 | 1006 | petitioner | CV of William J. Jusko, Ph.D. Download |
| Oct 20, 2023 | 1007 | petitioner | Declaration of Paul Dalby, Ph.D. Download |
| Oct 20, 2023 | 1008 | petitioner | CV of Paul Dalby, Ph.D. Download |
| Oct 20, 2023 | 1011 | petitioner | WO 2011/138421 Download |
| Oct 20, 2023 | 1012 | petitioner | Lovshin, Incretin-Based Therapies for Type 2 Diabetes Mellitus, 5 NATURE RE Download |
| Oct 20, 2023 | 1013 | petitioner | Clinical Trial No. NCT00696657 Download |
| Oct 20, 2023 | 1014 | petitioner | Clinical Trial No. NCT00851773 Download |
| Oct 20, 2023 | 1015 | petitioner | WO 2006/097537 Download |
| Oct 20, 2023 | 1016 | petitioner | U.S. Patent Application Pub. No. US2007/0010424 Download |
| Oct 20, 2023 | 1017 | petitioner | U.S. Patent No. 5,512,549 Download |
| Oct 20, 2023 | 1018 | petitioner | Banting, The Internal Secretion of the Pancreas, 7 J. LAB. CLINICAL MED. 25 Download |
| Oct 20, 2023 | 1019 | petitioner | Bell, Hamster Preproglucagon 302 NATURE 716 (1983) Download |
| Oct 20, 2023 | 1020 | petitioner | Bydureon prescribing information (Jan. 2012) Download |
| Oct 20, 2023 | 1021 | petitioner | Byetta prescribing information (Oct. 2009) Download |
| Oct 20, 2023 | 1022 | petitioner | Drab, Incretin-Based Therapies for Type 2 Diabetes PHARMA 609 (2010) Download |
| Oct 20, 2023 | 1023 | petitioner | Drucker, Enhancing Incretin Action 26 DIABETES CARE 2929 (2003) Download |
| Oct 20, 2023 | 1024 | petitioner | Drucker, The Incretin System, 368 LANCET 1696 (2006) Download |
| Oct 20, 2023 | 1025 | petitioner | Glaesner, Engineering, 26 DIABETES/METABOLISM RSCH. & REV. 287 (2010) Download |
| Oct 20, 2023 | 1026 | petitioner | Download |
| Oct 20, 2023 | 1027 | petitioner | Holst, Truncated Glucagon-like Peptide I, 211 (2) FEBS LETTERS 169 (1987) Download |
| Oct 20, 2023 | 1028 | petitioner | Holst, Glucagon-Like Peptide 1, CURRENT OP. IN PHARMACOLOGY 589 (2004) Download |
| Oct 20, 2023 | 1029 | petitioner | Jimenez-Solem, Dulaglutide, 12 current OP. in Molecular Therap. 90 (2010) Download |
| Oct 20, 2023 | 1030 | petitioner | Kim, Effects of Once-Weekly Dosing, 30 DIABETES CARE 1487 (2007) Download |
| Oct 20, 2023 | 1031 | petitioner | Knudsen, GLP-1 Derivatives, 26 DRUGS OF THE FUTURE 677 (2001) Download |
| Oct 20, 2023 | 1032 | petitioner | Knudsen, Glucagon-like Peptide-1, 47 J. MED. CHEMISTRY 4128 (2004) Download |
| Oct 20, 2023 | 1033 | petitioner | Knudsen, Liraglutide, Analogue-Based Drug (Fischer & Ganellin 2010) Download |
| Oct 20, 2023 | 1034 | petitioner | U.S. Patent No. 6,268,343 Download |
| Oct 20, 2023 | 1035 | petitioner | Lund, Emerging GLP-1 Receptor, 6 EXPERT OP. ON EMERGING DRUGS 607 (2011) Download |
| Oct 20, 2023 | 1036 | petitioner | Mojsov, Insulinotropin,79 J. CLINICAL INVESTIGATION 616 (1987) Download |
| Oct 20, 2023 | 1037 | petitioner | Nielsen, Pharmacology of Exenatide, 117 REGUL. PEPTIDES 77 (2004) Download |
| Oct 20, 2023 | 1038 | petitioner | Seino, Dose-Dependent, 81 DIABETES RSCH. & CLINICAL PRACTICE 161 (2008) Download |
| Oct 20, 2023 | 1039 | petitioner | Download |
| Oct 20, 2023 | 1040 | petitioner | Download |
| Oct 20, 2023 | 1041 | petitioner | WO 03/002136 Download |
| Oct 20, 2023 | 1042 | petitioner | WO 91/11457 Download |
| Oct 20, 2023 | 1043 | petitioner | U.S. Patent App. Pub. 2004/0102486 Download |
| Oct 20, 2023 | 1044 | petitioner | Rohatagi, Model-Based Development, 48 J. CLINICAL PHARMACOLOGY 1420 (2008) Download |
| Oct 20, 2023 | 1045 | petitioner | Shargel, APPLIED BIOPHARMACEUTICS & PHARMACOKINETICS (5th ed. 2005) Download |
| Oct 20, 2023 | 1046 | petitioner | Yun, Pharmacokinetic, 31 J. CLINICAL PHARMACY & THERAPEUTICS 469 (2006) Download |
| Oct 20, 2023 | 1047 | petitioner | Tamimi, Drug Development, 13 NEPHRON CLINICAL PRACTICE c125 (2009) Download |
| Oct 20, 2023 | 1048 | petitioner | FDA Guidance for Industry, Analysis, and Regulatory Applns. (Apr. 2003) Download |
| Oct 20, 2023 | 1049 | petitioner | Int'l Conf. on Harmonisation, 59 Fed. Reg. 55972 (Nov. 9, 1994 Download |
| Oct 20, 2023 | 1050 | petitioner | Garber, Efficacy of Metformin in Type II Diabetes,102 J.MED. 491 1997 Download |
| Oct 20, 2023 | 1051 | petitioner | Landersdorfer, Pharmacokinetic (47(7) CLINICAL PHARMACOKINETICS 417 (2008) Download |
| Oct 20, 2023 | 1052 | petitioner | Madsbad, An Overview, 13 DIABETES, OBESITY & METABOLISM 394 (2011) Download |
| Oct 20, 2023 | 1053 | petitioner | Download |
| Oct 20, 2023 | 1054 | petitioner | Landersdorfer, Mechanism-Based,73 BRIT. J. CLINICAL PHARMACOLOGY 391 (2011) Download |
| Oct 20, 2023 | 1055 | petitioner | Landersdorfer, Mechanism-Based 73 BRIT. J. CLINICAL PHARMACOLOGY 373 (2011) Download |
| Oct 20, 2023 | 1056 | petitioner | U.S. Patent No. 5,118,666 Download |
| Oct 20, 2023 | 1057 | petitioner | WO 2011/073328 Download |
| Oct 20, 2023 | 1058 | petitioner | Blonde, Comparison of Liraglutide(suppl. 2) DIABETES, OBES, & METAB. 2012 Download |
| Oct 20, 2023 | 1059 | petitioner | Murphy, Review of the Safety, 46 ANNALS OF PHARMACOTHERAPY 812 (2012) Download |
| Oct 20, 2023 | 1060 | petitioner | WO 2011/058193 Download |
| Oct 20, 2023 | 1061 | petitioner | U.S. Patent App. Pub. No. 2011/0166321 Download |
| Oct 20, 2023 | 1062 | petitioner | Zarin, The ClinicalTrials.gov Results Data, 364 NEW ENGL. J. MED. 852 2011 Download |
| Oct 20, 2023 | 1063 | petitioner | Kirillova, Results and Outcome,7(6) PLOS ONE 1 (2012) Download |
| Oct 20, 2023 | 1064 | petitioner | Monami, Effects of Glucagon-Like Peptide-1 EXPER. DIABETES RSCH. 1 (2012) Download |
| Oct 20, 2023 | 1065 | petitioner | Tasneem, The Database for Aggregate Analysis,7(3) PLOS ONE 1(2012) Download |
| Oct 20, 2023 | 1066 | petitioner | Download |
| Oct 20, 2023 | 1067 | petitioner | U.S. Patent No. 8,536,122 Download |
| Oct 20, 2023 | 1068 | petitioner | U.S. Patent No. 8,129,343 Download |
| Oct 20, 2023 | 1069 | petitioner | REMINGTON, THE SCIENC&PRACTICE, Alfonso R. Gennaro ed., 20th ed. 2000 Download |
| Oct 20, 2023 | 1070 | petitioner | Boylan, Parenteral Products, Gilbert S. Banker et al. eds., 3d ed. 1996 Download |
| Oct 20, 2023 | 1071 | petitioner | U.S. Patent No. 6,284,727 Download |
| Oct 20, 2023 | 1072 | petitioner | U.S. Patent No. 5,164,366 Download |
| Oct 20, 2023 | 1073 | petitioner | U.S. Patent No. 6,458,924 Download |
| Oct 20, 2023 | 1074 | petitioner | WO 00/37098 Download |
| Oct 20, 2023 | 1075 | petitioner | U.S. Patent No. 7,022,674 Download |
| Oct 20, 2023 | 1076 | petitioner | ClinicalTrials.gov Background, CLINICALTRIALS.GOV Download |
| Oct 20, 2023 | 1077 | petitioner | Award: ClinicalTrials.gov Download |
| Oct 20, 2023 | 1078 | petitioner | U.S. Patent App. Pub. No. 2004/0102486 Download |
| Oct 20, 2023 | 1079 | petitioner | NCT00167115, CLINICALTRIALS.GOV Download |
| Oct 20, 2023 | 1080 | petitioner | NCT01933490, CLINICALTRIALS.GOV Download |
| Oct 20, 2023 | 1081 | petitioner | Ozempic prescribing information (Oct. 2022) Download |
| Oct 20, 2023 | 1082 | petitioner | Scheduling Order, No. 22-294 (CFC), D. Del. June 30, 2022, ECF No. 22 Download |
| Oct 20, 2023 | 1083 | petitioner | Transfer Order, In re: Ozempic, No. 3038 (MDL Aug. 5, 2022) Download |
| Oct 20, 2023 | 1084 | petitioner | EMA, ICH Topic S 7 A Safety Pharma. Studies for Human Pharma. June 2001 Download |
| Oct 20, 2023 | 1085 | petitioner | ACS Publications Download |
| Oct 20, 2023 | 1086 | petitioner | Download |
| Oct 20, 2023 | 1087 | petitioner | Prosecution history excerpts for U.S. Patent No. 9,764,003 Download |
| Oct 20, 2023 | 1088 | petitioner | Markman Hearing Transpt. Re: OzempicNo. 22-MD-3038 (D. Del. July 13, 2023) Download |
| Oct 20, 2023 | 1089 | petitioner | Claim Construction Order, No. 22-MD-3038 (D. Del. July 25, 2023), ECF 148 Download |
| Oct 20, 2023 | 1090 | petitioner | Joint Claim Construction Brief, No. 22-MD-3038 D.Del. May 1, 2023), ECF 119 Download |
| Oct 20, 2023 | 1091 | petitioner | Declaration of Dr. Russell M. Zusman Download |
| Oct 20, 2023 | 1092 | petitioner | CV of Dr. Russell M. Zusman Download |
| Oct 20, 2023 | 1093 | petitioner | Declaration of Dr. John P. Fruehauf Download |
| Oct 20, 2023 | 1094 | petitioner | CV of Dr. John P. Fruehauf Download |
| Oct 20, 2023 | 1095 | petitioner | Declaration of Dr. Maureen M. Donovan Download |
| Oct 20, 2023 | 1096 | petitioner | CV of Dr. Maureen M. Donovan Download |
| Oct 20, 2023 | 1097 | petitioner | Mylan Pharma. Inc., v. Novo Nordisk IPR2023-00724, Paper 10, Oct. 4, 2023 Download |
| Oct 20, 2023 | 2 | petitioner | IPR Petition DRL '462 Download |
| Oct 20, 2023 | 3 | petitioner | Download |
